BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33369444)

  • 1. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
    Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients.
    Bhandari P; Ahmad F; Das BR
    Med Oncol; 2017 May; 34(5):92. PubMed ID: 28401483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia.
    Gupta SK; Bakhshi S; Kumar L; Kamal VK; Kumar R
    Leuk Lymphoma; 2017 Feb; 58(2):333-342. PubMed ID: 27339065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of copy number abnormalities in common genes associated with B-cell precursor acute lymphoblastic leukemia cytogenetic subtypes in Brazilian children.
    Barbosa TC; Terra-Granado E; Quezado Magalhães IM; Neves GR; Gadelha A; Guedes Filho GE; Souza MS; Melaragno R; Emerenciano M; Pombo-de-Oliveira MS
    Cancer Genet; 2015 Oct; 208(10):492-501. PubMed ID: 26277549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
    Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
    Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
    Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia.
    Schwab CJ; Jones LR; Morrison H; Ryan SL; Yigittop H; Schouten JP; Harrison CJ
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1104-13. PubMed ID: 20815030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.
    Schwab CJ; Chilton L; Morrison H; Jones L; Al-Shehhi H; Erhorn A; Russell LJ; Moorman AV; Harrison CJ
    Haematologica; 2013 Jul; 98(7):1081-8. PubMed ID: 23508010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Copy number alterations in adult patients with mature B acute lymphoblastic leukemia treated with specific immunochemotherapy].
    Ribera J; Zamora L; García O; Hernández-Rivas JM; Genescà E; Ribera JM
    Med Clin (Barc); 2016 Dec; 147(11):488-491. PubMed ID: 28126143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.
    Yu CH; Lin TK; Jou ST; Lin CY; Lin KH; Lu MY; Chen SH; Cheng CN; Wu KH; Wang SC; Chang HH; Li MJ; Ni YL; Su YN; Lin DT; Chen HY; Harrison CJ; Hung CC; Lin SW; Yang YL
    Sci Rep; 2020 Jul; 10(1):11501. PubMed ID: 32661308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Boer JM; Hoogkamer AQ; Boeree A; de Haas V; de Groot-Kruseman HA; Horstmann MA; Escherich G; Pieters R; den Boer ML
    Sci Rep; 2019 Mar; 9(1):4634. PubMed ID: 30874617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy Number Alteration Profile Provides Additional Prognostic Value for Acute Lymphoblastic Leukemia Patients Treated on BFM Protocols.
    Ampatzidou M; Florentin L; Papadakis V; Paterakis G; Tzanoudaki M; Bouzarelou D; Papadhimitriou SI; Polychronopoulou S
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemia.
    Patkar N; Subramanian PG; Tembhare P; Mandalia S; Chaterjee G; Rabade N; Kodgule R; Chopra K; Bibi A; Joshi S; Chaudhary S; Mascerhenas R; Kadam-Amare P; Narula G; Arora B; Banavali S; Gujral S
    Indian J Pathol Microbiol; 2017; 60(2):209-213. PubMed ID: 28631637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
    Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
    Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IKZF1
    Stanulla M; Dagdan E; Zaliova M; Möricke A; Palmi C; Cazzaniga G; Eckert C; Te Kronnie G; Bourquin JP; Bornhauser B; Koehler R; Bartram CR; Ludwig WD; Bleckmann K; Groeneveld-Krentz S; Schewe D; Junk SV; Hinze L; Klein N; Kratz CP; Biondi A; Borkhardt A; Kulozik A; Muckenthaler MU; Basso G; Valsecchi MG; Izraeli S; Petersen BS; Franke A; Dörge P; Steinemann D; Haas OA; Panzer-Grümayer R; Cavé H; Houlston RS; Cario G; Schrappe M; Zimmermann M; ;
    J Clin Oncol; 2018 Apr; 36(12):1240-1249. PubMed ID: 29498923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction.
    Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
    Leuk Res; 2018 Mar; 66():79-84. PubMed ID: 29407587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic gene alterations and clonal changes in childhood B-ALL.
    Erbilgin Y; Firtina S; Mercan S; Hatirnaz Ng O; Karaman S; Tasar O; Karakas Z; Celkan TT; Zengin E; Sarper N; Yildirmak ZY; Sisko S; Ozbek U; Sayitoglu M
    Leuk Res; 2019 Aug; 83():106159. PubMed ID: 31228652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin dependent kinase inhibitor 2A/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemia.
    Agarwal M; Bakhshi S; Dwivedi SN; Kabra M; Shukla R; Seth R
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27001. PubMed ID: 29446543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification].
    Zhang L; Liu XM; Guo Y; Yang WY; Zhang JY; Liu F; Liu TF; Wang SC; Chen XJ; Ruan M; Qi BQ; Chang LX; Zou Y; Chen YM; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Jan; 18(1):34-8. PubMed ID: 26781410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.